Eli Lilly and Company: all 2,262 studies
Page 23 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- Duloxetine vs. Active Comparator for the Treatment of DepressionCompletedNCT00067912Phase 4
- A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCompletedNCT00067730Phase 4
- Pemetrexed as First Line Chemotherapy for Advanced Breast CancerCompletedNCT00065533Phase 2
- An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 DiabetesCompletedNCT00065312Phase 2
- Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube CancerCompletedNCT00063401Phase 2
- Phase II Study in Patients With Recurrent Non-Small-Cell Lung CancerCompletedNCT00063388Phase 2
- Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00063141Phase 3
- Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.CompletedNCT00063128Phase 2
- Study of Duloxetine in Elderly Patients With Major Depressive DisorderCompletedNCT00062673Phase 3
- Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal CancerCompletedNCT00061815Phase 3
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal MesotheliomaCompletedNCT00061477Phase 2
- Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.CompletedNCT00061464Phase 2
- Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical TrialCompletedNCT00061451Phase 2
- A Study for the Treatment of Painful Diabetic NeuropathyCompletedNCT00058968Phase 3
- Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal CancerTerminatedNCT00055432Phase 2
- A Study of Cetuximab in Patients Who Have Stage IV Colorectal CancerCompletedNCT00055419Phase 2
- A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic CancerCompletedNCT00055250Phase 2
- Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's DiseaseCompletedNCT00051909Phase 2
- ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.CompletedNCT00051506Phase 2
- ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.CompletedNCT00051493Phase 2
- Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCompletedNCT00051298Phase 3
- Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach EmptyingCompletedNCT00050609Phase 2
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I DisorderCompletedNCT00050206Phase 4
- A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)CompletedNCT00049777Phase 4
- Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe SepsisCompletedNCT00049764Phase 3
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With OsteoporosisCompletedNCT00046137Phase 3
- The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe SepsisCompletedNCT00045760Phase 4
- Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal CarcinomaCompletedNCT00044863Phase 2
- Treatment of Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044421Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCompletedNCT00044187Phase 4
- A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.CompletedNCT00042679Phase 2
- Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major DepressionCompletedNCT00042575Phase 3
- Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major DepressionCompletedNCT00042562Phase 3
- ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.Approved for marketingNCT00040625
- Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCGCompletedNCT00037713Phase 3
- Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without InsulinCompletedNCT00036504Phase 4
- Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and PainCompletedNCT00036335Phase 3
- Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive DisorderCompletedNCT00036309Phase 3
- Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCompletedNCT00036088Phase 4
- A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung InjuryCompletedNCT00036062Phase 1/2
- EVA: Evista Alendronate ComparisonCompletedNCT00035971Phase 4
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant DepressionCompletedNCT00035321Phase 3
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00035256Phase 4
- A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumCompletedNCT00035061Phase 2
- A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.CompletedNCT00035035Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
- A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.CompletedNCT00034619Phase 2
- Comparing 3 Schedules of Alimta Plus GemzarCompletedNCT00034606Phase 2
- A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00034593Phase 2
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I DisorderCompletedNCT00034580Phase 4
- Study of gp75 Vaccine in Patients With Stage III and IV MelanomaCompletedNCT00034554Phase 1
- Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT00034541Phase 1/2
- A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.CompletedNCT00034502Phase 1/2
- A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.CompletedNCT00034489Phase 2
- A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe SepsisCompletedNCT00034476Phase 1/2
- ALIMTA (Pemetrexed) in Patients With Locally Advanced or Metastatic CancerCompletedNCT00034463Phase 1
- A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung CancerCompletedNCT00034268Phase 3
- Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.CompletedNCT00034125Phase 3
- Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast CancerCompletedNCT00006459Phase 3
- Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003670Phase 2
- Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial CancerCompletedNCT00003669Phase 2